Asidefrom the aforementioned stomach safety study, called VIGOR, Merck also did a smaller study, called 090, which compared Vioxx to a placebo over six weeks.
But asidefrom beefing up drug company inspections abroad and tightening food safety regulations, there is no justification for the FDA to receive additional funding.